Ongericimab (Anti-PCSK9)
Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2987 |
| Sku # | A2987-1mg*25 |
| Pricing | 1mg*25, $5070.00 |